Teleflex Incorporated (NYSE:TFX – Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 14th, there was short interest totaling 4,835,328 shares, an increase of 59.7% from the July 30th total of 3,027,778 shares. Currently, 11.5% of the shares of the company are sold short. Based on an average daily trading volume, of 760,689 shares, the days-to-cover ratio is currently 6.4 days.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on TFX shares. Wells Fargo & Company boosted their target price on Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Raymond James Financial reissued an “outperform” rating and issued a $150.00 target price on shares of Teleflex in a research report on Friday, May 8th. Piper Sandler reissued an “overweight” rating and issued a $169.00 price target (up from $160.00) on shares of Teleflex in a research report on Friday, August 7th. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and boosted their target price for the stock from $135.00 to $155.00 in a research report on Friday, May 8th. Finally, UBS Group raised their price target on Teleflex from $145.00 to $158.00 and gave the company a “neutral” rating in a research report on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $152.90.
Get Our Latest Analysis on Teleflex
Institutional Trading of Teleflex
Teleflex Stock Up 1.2%
NYSE TFX traded up $1.63 during trading hours on Wednesday, hitting $142.11. 432,356 shares of the company traded hands, compared to its average volume of 775,657. Teleflex has a twelve month low of $100.18 and a twelve month high of $145.00. The stock has a market capitalization of $6.02 billion, a price-to-earnings ratio of -6.10, a P/E/G ratio of 0.95 and a beta of 0.82. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. The business’s 50-day moving average is $134.59 and its 200-day moving average is $126.54.
Teleflex (NYSE:TFX – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.48. The business had revenue of $570.33 million during the quarter, compared to analysts’ expectations of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The firm’s revenue for the quarter was up 28.9% compared to the same quarter last year. During the same period last year, the firm posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Sell-side analysts anticipate that Teleflex will post 7.26 earnings per share for the current year.
Teleflex Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Friday, August 14th. Teleflex’s dividend payout ratio (DPR) is currently -5.84%.
About Teleflex
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Featured Articles
- Five stocks we like better than Teleflex
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
- Strategic Strike: Strategy Deploys $370M to Fortify Bitcoin
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
